View Post

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

In In The News by Barbara Jacoby0 Comments

From: PR Newswire Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors. “We are pleased to expand the use of this product for cancer patients with …

View Post

Doctors Excited By Results Of New Immunotherapy Cancer Treatment

In In The News by Barbara Jacoby0 Comments

By: Dr. Maria Simbra From: pittsburgh.cbslocal.com No chemotherapy, No radiation. There’s a new way to treat cancer that doesn’t involve either. It’s working for patients and even doctors are excited about it. Joe Milcarek had no symptoms of lung cancer. Doctors discovered it on scans he had as part of participation in a lung study. “They found a tumor about …

View Post

Cancer cells metastasize far earlier than suspected

In In The News by Barbara Jacoby0 Comments

By: Bradley J. Fikes From: sandiegouniontribune.com Solid tumors can metastasize far earlier than previously thought, according to a study by scientists at The Scripps Research Institute. Tumor cells nearly always get into the bloodstream at the core, not the periphery, as the conventional model states. These cells become mobile before the primary tumor starts invading nearby tissue, the study found. …

View Post

New drug delivery system shows promise for fighting solid tumors

In In The News by Barbara Jacoby0 Comments

A new cancer-drug delivery system shows the ability to exploit the oxygen-poor areas of solid tumors that make the growths resistant to standard chemotherapy and radiation treatment. Carcinomas that affect the breast, lung, prostate and colon are among these solid-tumor cancers, as are malignancies in the lymphatic system, known as lymphomas, and the much less common sarcomas that arise in …

View Post

Study uncovers mechanism that causes chemo resistance of pancreatic cancer cells

In In The News by Barbara Jacoby0 Comments

Source: University of Liverpool From: www.news-medical.net A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy. Pancreatic cancer is one of the leading causes of cancer death and current therapies are not very effective. Thus, a better understanding of the molecular mechanisms …

View Post

Potential cancer treatment uses microwaves to target tumors

In In The News by Barbara Jacoby0 Comments

By: Ryan Maass From: upi.com Researchers at the University of Texas at Arlington demonstrated that microwaves can be used to target tumors directly during cancer treatment. In the study, published in the Journal of Biomedical Nanotechnology, authors suggest the photosensitive nanoparticles activated by microwaves can lead to the death of cells within solid tumors. Researchers observed microwaves influenced significant cell …

View Post

ONC201 Continues to Show Excellent Safety When Dosed Weekly

In In The News by Barbara Jacoby0 Comments

Oncoceutics, Inc. announced the successful completion of the dose escalation phase of a clinical trial for the company’s lead molecule ONC201 using weekly dosing.  Oncoceutics has previously reported the exceptional safety profile for ONC201 in multiple clinical trials using a dosing regimen of once every three weeks. The weekly cohort was part of a trial entitled “Oral ONC201 in Treating …

View Post

Protein key to combating lung cancer identified

In In The News by Barbara Jacoby0 Comments

By: IANS From: indianexpress.com The researchers believe that the findings of this study would contribute to the development of better therapies for cancer patients. Medical researchers have found that inhibiting a protein called BMI1 could impair tumour growth in lung cancer. Reducing the levels of BMI1 by genetic means, or by using a drug reducing expression of BMI1, led to inhibition …

View Post

Cell Medica, Baylor partner on next-gen CAR-T cancer therapies

In In The News by Barbara Jacoby0 Comments

By: Ben Adams From: fiercebiotech.com London-based Cell Medica, one of last year’s Fierce 15, has signed a pact with Houston’s Baylor College of Medicine to find and develop next-gen tech for engineering immune cells in tumors. In a joint statement, the two saw the “ground-breaking” co-development partnership will see Cell Medica gain an exclusive license over several Baylor cell and …

View Post

Personalized Medicine Leads to Better Outcomes for Patients with Cancer

In In The News by Barbara Jacoby0 Comments

Frin: UCSD Health Sciences Communications In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials. The …